Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com Prev Post Multiple New Multi-Commodity Targets May 12, 2025 Next Post Excellent Gold Intersections Verified at Kiimala Project May 12, 2025 Related Posts U.S. Investors Lead Oversubscribed $17m Placement December 8, 2025 Questcorp Mining Announces Flow Through Offering December 8, 2025 Locksley Resources LimitedU.S. Investors Lead Oversubscribed $17m Placement December 8, 2025